title: A diarylheptanoid phytoestrogen from Curcuma comosa, 1,7-diphenyl-4,6-heptadien-3-ol, accelerates human osteoblast proliferation and differentiation.
abstract: Curcuma comosa Roxb. is ginger-family plant used to relieve menopausal symptoms. Previous work showed that C. comosa extracts protect mice from ovariectomy-induced osteopenia with minimal effects on reproductive organs, and identified the diarylheptanoid (3R)-1,7-diphenyl-(4E,6E)-4,6-heptadien-3-ol (DPHD) as the major active component of C. comosa rhizomes. At 1-10μM, DPHD increased differentiation in transformed mouse osteoblasts, but the effect of DPHD on normal bone cells was unknown. We examined the concentration dependency and mechanism of action of DPHD relative to 17β-estradiol in nontransformed human osteoblasts (h-OB). The h-OB were 10-100 fold more sensitive to DPHD than transformed osteoblasts: DPHD increased h-OB proliferation at 10nM and, at 100nM, activated MAP kinase signaling within 30 min. In long-term differentiation assays, responses of h-OB to DPHD were significant at 10nM, and optimal response in most cases was at 100 nM. At 7-21 days, DPHD accelerated osteoblast differentiation, indicated by alkaline phosphatase activity and osteoblast-specific mRNA production. Effects of DPHD were eliminated by the estrogen receptor antagonist ICI182780. During differentiation, DPHD promoted early expression of osteoblast transcription factors, RUNX2 and osterix. Subsequently, DPHD accelerated production of bone structural genes, including COL1A1 and osteocalcin comparably to 17β-estradiol. In h-OB, DPHD increased the osteoprotegerin to RANKL ratio and supported mineralization more efficiently than 10nM 17β-estradiol. We conclude that DPHD promotes human osteoblast function in vitro effectively at nanomolar concentrations, making it a promising compound to protect bone in menopausal women.
authors.affiliation: Department of Physiology, Mahidol University, Bangkok 10400, Thailand.
authors.forename: Duangrat
authors.initials: D
authors.lastname: Tantikanlayaporn
authors.forename: Lisa J
authors.initials: LJ
authors.lastname: Robinson
authors.forename: Apichart
authors.initials: A
authors.lastname: Suksamrarn
authors.forename: Pawinee
authors.initials: P
authors.lastname: Piyachaturawat
authors.forename: Harry C
authors.initials: HC
authors.lastname: Blair
mesh_terms: D002454:Cell Differentiation / Q000187:drug effects*; D049109:Cell Proliferation / Q000187:drug effects*; D030024:Curcuma / Q000737:chemistry*; D036381:Diarylheptanoids / Q000737:chemistry / Q000378:metabolism / Q000494:pharmacology; D004958:Estradiol / Q000737:chemistry / Q000494:pharmacology; D005260:Female; D019850:Heptanol / Q000031:analogs & derivatives; D006801:Humans; D020935:MAP Kinase Signaling System / Q000187:drug effects; D008593:Menopause / Q000187:drug effects; D010006:Osteoblasts / Q000187:drug effects*; D015675:Osteocalcin / Q000378:metabolism / Q000494:pharmacology; D010024:Osteoporosis / Q000188:drug therapy; D053244:Osteoprotegerin / Q000235:genetics / Q000378:metabolism; D048789:Phytoestrogens / Q000737:chemistry / Q000302:isolation & purification / Q000494:pharmacology*; D010936:Plant Extracts / Q000737:chemistry / Q000302:isolation & purification / Q000494:pharmacology*; D053245:RANK Ligand / Q000235:genetics / Q000378:metabolism; D012333:RNA, Messenger / Q000235:genetics; D027343:Rhizome / Q000737:chemistry
chemical_list: C558048:1,7-diphenyl-4,6-heptadien-3-ol; D036381:Diarylheptanoids; D053244:Osteoprotegerin; D048789:Phytoestrogens; D010936:Plant Extracts; D053245:RANK Ligand; D012333:RNA, Messenger; D015675:Osteocalcin; D004958:Estradiol; D019850:Heptanol
references.citation: Environ Health Perspect. 2009 Jul;117(7):1155-61
references.pmid: 19654927
references.citation: Exp Cell Res. 2009 Apr 15;315(7):1287-301
references.pmid: 19331827
references.citation: Biochem Biophys Res Commun. 1997 Jun 9;235(1):99-102
references.pmid: 9196043
references.citation: Climacteric. 2012 Dec;15(6):513-23
references.pmid: 22853318
references.citation: J Clin Invest. 2005 Dec;115(12):3318-25
references.pmid: 16322775
references.citation: Endocr Rev. 2002 Jun;23(3):279-302
references.pmid: 12050121
references.citation: J Bone Miner Res. 2001 Nov;16(11):2118-25
references.pmid: 11697809
references.citation: J Endocrinol Invest. 2013 Jan;36(1):21-7
references.pmid: 22453024
references.citation: J Cell Biochem. 1996 Jun 15;61(4):629-37
references.pmid: 8806087
references.citation: J Biol Chem. 2012 Oct 19;287(43):36168-78
references.pmid: 22936801
references.citation: Br J Nutr. 2011 Oct;106(7):1063-9
references.pmid: 21736835
references.citation: Cell Stem Cell. 2012 Mar 2;10(3):233-4
references.pmid: 22385649
references.citation: J Ethnopharmacol. 2011 Sep 2;137(2):956-62
references.pmid: 21762769
references.citation: Menopause. 2011 Jan;18(1):109-18
references.pmid: 20661164
references.citation: Clin Cornerstone. 2008;9(2):42-7; discussion 48-50
references.pmid: 19410161
references.citation: Basic Clin Pharmacol Toxicol. 2006 Mar;98(3):288-96
references.pmid: 16611204
references.citation: Biochem Cell Biol. 1998;76(6):899-910
references.pmid: 10392704
references.citation: J Agric Food Chem. 2009 Feb 11;57(3):840-5
references.pmid: 19143535
references.citation: Bioorg Med Chem. 2008 Jul 15;16(14):6891-902
references.pmid: 18554915
references.citation: Horm Metab Res. 2012 Jun;44(7):494-500
references.pmid: 22556124
references.citation: Lab Invest. 2012 Jul;92(7):1071-83
references.pmid: 22546867
references.citation: Mol Endocrinol. 2010 Apr;24(4):709-21
references.pmid: 20197310
references.citation: Health Technol Assess. 2005 Jun;9(22):1-160
references.pmid: 15929857
references.citation: Trends Endocrinol Metab. 2005 Jul;16(5):207-13
references.pmid: 15922618
references.citation: J Cell Biochem. 2003 May 1;89(1):152-64
references.pmid: 12682916
references.citation: J Clin Densitom. 2011 Jan-Mar;14(1):47-57
references.pmid: 21295742